-
26 Avril 2018
-
26 Avril 2018
-
25 Juillet 2019
-
25 Juillet 2019
Ipsen delivers strong results for the first half of 2019 with robust double-digit sales growth and improved Core Operating margin and upgrades its guidance for full year 2019
Extract of audited consolidated results for H1 2019 and 2018...
-
18 Avril 2019
-
18 Avril 2019
-
06 Mars 2019
-
06 Mars 2019
Ipsen to Present Improvements to Somatuline® Autogel® Pre-filled Syringe at the 16th European Neuroendocrine Tumor Society (ENETS) Annual Conference
ENETS abstract coincides with first European launch...
-
12 Janvier 2018
-
12 Janvier 2018
-
15 Novembre 2018
-
15 Novembre 2018
-
25 Février 2019
-
25 Février 2019
-
14 Février 2019
-
14 Février 2019
Ipsen delivers strong 2018 results and expects continued sales and profit growth in 2019
Paris (France), 14 February 2019 – Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty-driven biopharmaceutical group, today announced its financial results for the full year 2018....
-
16 Janvier 2018
-
16 Janvier 2018